4//SEC Filing
China Biologic Products, Inc. 4
Accession 0001144204-16-104221
CIK 0001369868operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:36 PM ET
Size
15.1 KB
Accession
0001144204-16-104221
Insider Transaction Report
Form 4
Yin Ming
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2016-05-16$12.26/sh+30,000$367,800→ 51,419 total - Sale
Common Stock
2016-05-19$113.83/sh−10,973$1,249,057→ 40,446 total - Sale
Common Stock
2016-05-20$113.40/sh−8,645$980,343→ 31,801 total - Exercise/Conversion
Stock Option (right to buy)
2016-05-16−30,000→ 15,452 totalExercise: $12.26From: 2010-10-11Exp: 2020-07-11→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2016-05-16−7,952→ 7,500 totalExercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common Stock (7,952 underlying)
Footnotes (5)
- [F1]Represents 10,973 shares of common stock (the "May 19 Sold Common Stock") sold on the open market at a weighted average price of $113.83 per share on May 19, 2016, and 8,645 shares of common stock (the "May 20 Sold Common Stock," and together with the May 19 Sold Common Stock, the "Sold Stock") sold on the open market at a weighted average price of $113.40 per share on May 20, 2016. The Sold Stock was acquired by the Reporting Person through the exercise of stock options to purchase 30,000 shares of the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options. The Reporting Person intends to use the proceeds from the sales of the Sold Stock to pay income tax due in connection with the Reporting Person's exercise of the stock options disclosed in Footnotes 4 and 5 to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. The May 19 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.50 to $115.35, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3 to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The May 20 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.00 to $114.00, inclusive.
- [F4]Represents previously reported stock options to purchase 30,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010. The options were scheduled to vest in 12 equal portions on a quarterly basis over a three-year period, with the initial vesting date being October 11, 2010, provided that the Reporting Person is employed by the Issuer on each vesting date.
- [F5]Represents previously reported stock options to purchase 7,952 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
Documents
Issuer
China Biologic Products, Inc.
CIK 0001369868
Entity typeoperating
Related Parties
1- filerCIK 0001369868
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:36 PM ET
- Size
- 15.1 KB